This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Alpha Tau Medical Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Innovations in Radiotherapy by Guy Keret
Introduction
Guy Keret is an accomplished inventor based in Beit Yehoshua, Israel. He has made significant contributions to the field of radiotherapy, particularly through his innovative patents. With a total of 2 patents, Keret's work focuses on enhancing the effectiveness and safety of cancer treatment.
Latest Patents
Keret's latest patents include groundbreaking technologies in the realm of brachytherapy. One of his notable inventions is a casing designed to hold one or more brachytherapy seeds for implantation in patients. This casing is filled with a viscous liquid that prevents radiation from escaping, ensuring a safer treatment environment. Additionally, he has developed a controlled release brachytherapy device that allows for the gradual emission of radionuclide atoms, optimizing the therapeutic effects while minimizing potential side effects.
Career Highlights
Guy Keret is currently associated with Alpha Tau Medical Ltd., where he continues to innovate in the field of medical technology. His work has been instrumental in advancing treatment options for patients undergoing radiotherapy. Keret's dedication to improving patient outcomes through innovative solutions is evident in his research and development efforts.
Collaborations
Throughout his career, Keret has collaborated with esteemed colleagues such as Itzhak Kelson and Yona Keisari. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work in the medical field.
Conclusion
Guy Keret's contributions to radiotherapy through his innovative patents demonstrate his commitment to improving cancer treatment. His work not only advances medical technology but also holds the potential to significantly enhance patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile